Development and application of therapeutic antibodies against COVID-19

The pandemic of Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2) continues to be a global health crisis. Fundamental studies at genome, transcriptome, proteome, and interactome levels have revealed many viral and host targets for therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Lin, Abagna, Hamza B., Jiang, Qianhu, Liu, Siqi, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071770/
https://www.ncbi.nlm.nih.gov/pubmed/33907512
http://dx.doi.org/10.7150/ijbs.59149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071770/
https://www.ncbi.nlm.nih.gov/pubmed/33907512
http://dx.doi.org/10.7150/ijbs.59149

Ejemplares similares